PF-3845

News alerts, weekly reports and conference planners

Company:

Pfizer

Drug class:

FAAH inhibitor

‹

›

PIK3CA overexpression	Squamous Cell Carcinoma of Head and Neck	PIK3CA overexpression	Squamous Cell Carcinoma of Head and Neck	PF-3845 Resistant: D – Preclinical PF-3845 Resistant : D	PF-3845 Resistant: D – Preclinical PF-3845 Resistant : D
PIK3CA H1047R	Squamous Cell Carcinoma of Head and Neck	PIK3CA H1047R	Squamous Cell Carcinoma of Head and Neck	PF-3845 Resistant: D – Preclinical PF-3845 Resistant : D	PF-3845 Resistant: D – Preclinical PF-3845 Resistant : D

Associations
(2)